 DERMADEX
|
GlaxoSmithKline Biopharma
|
| clobetasol |
Antieccematoso |
| cr.x 15 g | $21.674,15 | (02/03/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $8.669,66 AF $13.004,49 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $4.998,62 AF $16.675,53 |
|
|
|
|
| cr.x 30 g | $42.505,36 | (02/03/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $17.002,14 AF $25.503,22 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $5.928,25 AF $36.577,11 |
|
|
|
|
| ung.x 15 g | $20.540,37 | (02/03/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $8.216,15 AF $12.324,22 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $4.998,62 AF $15.541,75 |
|
|
|
|
| ung.x 30 g | $39.367,58 | (02/03/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $15.747,03 AF $23.620,55 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $5.928,25 AF $33.439,33 |
|
|
|
|
| |
